Health

More Exercise Better Even in the Elderly

A randomized controlled trial in Norway suggested a lower all-cause mortality trend after high intensity interval training at about 90% of peak heart rate (HIIT) compared with controls and moderate intensity continuous training at about 70% of peak heart rate (MICT) in older adults. The trial included 1567 participants (790 women) with mean age of 72.8 years. Overall, 87.5% of participants reported to have overall good health, with 80% reporting medium or high physical activity levels at baseline. When two sessions weekly of HIIT was compared with MICT and control group, an absolute risk reduction of 2.9% and 1.7% (hazard ratio 0.51 and 0.63), respectively was observed for all-cause mortality. However, the controls achieved an exercise dose at an intensity between the MICT and HIIT groups due to more control participants chose to perform more of their physical activity as HIIT. The findings are in line with accumulating evidence that some exercise is good, more is better even in the elderly. Source: https://www.bmj.com/

hyangiu

Recent Posts

Global Study of Stroke Risk Factors

A study revealed that stroke remains a major global health challenge, influenced by numerous risk…

2 days ago

Antidepressants Effective and Safe in Older Adults with Anxiety

A systematic review and meta-analysis evaluated randomized controlled trials on pharmacological treatments for anxiety in…

3 days ago

Geographical Variation in Lipoprotein (a) Levels Among CHD Patients

A global study suggested that most patients with coronary heart disease (CHD) have Lipoprotein (a)…

2 weeks ago

The Science and Skepticism around Seed Oils

A recent article explored the science and skepticism surrounding seed oils. These oils—extracted from sources…

3 weeks ago

Bedtime Antihypertensive Comparable to Morning Use

A Canadian study of adults with high blood pressure (BP) found no difference in health…

4 weeks ago

Obicetrapib Effective and Safe in Improving Lipids

Two randomized, controlled trials evaluated the efficacy and safety of obicetrapib, an oral cholesteryl ester…

1 month ago

This website uses cookies.